GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Zhenyuan Share Co Ltd (SZSE:000705) » Definitions » Beneish M-Score

Zhejiang Zhenyuan Share Co (SZSE:000705) Beneish M-Score : -2.55 (As of Apr. 10, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Zhejiang Zhenyuan Share Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.55 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Zhejiang Zhenyuan Share Co's Beneish M-Score or its related term are showing as below:

SZSE:000705' s Beneish M-Score Range Over the Past 10 Years
Min: -5.01   Med: -2.48   Max: -1.92
Current: -2.55

During the past 13 years, the highest Beneish M-Score of Zhejiang Zhenyuan Share Co was -1.92. The lowest was -5.01. And the median was -2.48.


Zhejiang Zhenyuan Share Co Beneish M-Score Historical Data

The historical data trend for Zhejiang Zhenyuan Share Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Zhenyuan Share Co Beneish M-Score Chart

Zhejiang Zhenyuan Share Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -2.64 -2.36 -2.02 -2.69

Zhejiang Zhenyuan Share Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.82 -2.69 -2.62 -2.57 -2.55

Competitive Comparison of Zhejiang Zhenyuan Share Co's Beneish M-Score

For the Drug Manufacturers - General subindustry, Zhejiang Zhenyuan Share Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Zhenyuan Share Co's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Zhenyuan Share Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zhejiang Zhenyuan Share Co's Beneish M-Score falls into.


;
;

Zhejiang Zhenyuan Share Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zhejiang Zhenyuan Share Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0692+0.528 * 1.0147+0.404 * 1.1989+0.892 * 0.9151+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9454+4.679 * -0.020079-0.327 * 1.187
=-2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ¥668 Mil.
Revenue was 892.781 + 914.191 + 1044.651 + 985.956 = ¥3,838 Mil.
Gross Profit was 169.241 + 187.411 + 189.486 + 168.097 = ¥714 Mil.
Total Current Assets was ¥2,028 Mil.
Total Assets was ¥3,267 Mil.
Property, Plant and Equipment(Net PPE) was ¥765 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥261 Mil.
Total Current Liabilities was ¥1,028 Mil.
Long-Term Debt & Capital Lease Obligation was ¥164 Mil.
Net Income was 0.045 + 24.278 + 19.246 + 11.757 = ¥55 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 20.844 + 92.423 + 43.926 + -36.269 = ¥121 Mil.
Total Receivables was ¥683 Mil.
Revenue was 1004.639 + 1017.669 + 1098.107 + 1073.339 = ¥4,194 Mil.
Gross Profit was 207.052 + 196.657 + 195.419 + 192.894 = ¥792 Mil.
Total Current Assets was ¥2,095 Mil.
Total Assets was ¥3,040 Mil.
Property, Plant and Equipment(Net PPE) was ¥577 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥302 Mil.
Total Current Liabilities was ¥891 Mil.
Long-Term Debt & Capital Lease Obligation was ¥44 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(668.129 / 3837.579) / (682.915 / 4193.754)
=0.174102 / 0.162841
=1.0692

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(792.022 / 4193.754) / (714.235 / 3837.579)
=0.188858 / 0.186116
=1.0147

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2027.96 + 764.517) / 3266.971) / (1 - (2095.285 + 576.515) / 3040.093)
=0.14524 / 0.121145
=1.1989

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3837.579 / 4193.754
=0.9151

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 576.515)) / (0 / (0 + 764.517))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(260.913 / 3837.579) / (301.592 / 4193.754)
=0.067989 / 0.071915
=0.9454

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((163.975 + 1027.879) / 3266.971) / ((43.817 + 890.511) / 3040.093)
=0.364819 / 0.307335
=1.187

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(55.326 - 0 - 120.924) / 3266.971
=-0.020079

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zhejiang Zhenyuan Share Co has a M-score of -2.55 suggests that the company is unlikely to be a manipulator.


Zhejiang Zhenyuan Share Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Zhejiang Zhenyuan Share Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Zhenyuan Share Co Business Description

Traded in Other Exchanges
N/A
Address
No. 558, Yan'an East Road, Jishan Street, Yuecheng District, Zhejiang Province, Shaoxing, CHN, 312000
Zhejiang Zhenyuan Share Co Ltd is a China based pharmaceutical company. It is engaged in the engaged in the production and operation of proprietary Chinese medicines, Chinese herbal medicines, Chinese herbal medicines, chemical preparations, chemical raw materials, biochemical drugs, narcotic drugs, psychotropic drugs, medical devices, chemical reagent and others. Further, the firm's business scope covers the pharmaceutical industry, pharmaceutical business, pharmaceutical logistics and health service industry. It holds presence in both Chinese and international market.
Executives
Zhang Yan Na Supervisors
Wu Hai Ming Director
Chen Fu Gen Directors, executives
Wei Min Executives
He Yi Qiang Directors, executives
Dong Jin Biao Supervisors
Xuan Le Xin Supervisors
Jiang Guan Gen Supervisors
Song Yi Ting Directors, executives
Li Cheng Hua Executives
He Yu Long Directors, executives
Li Yang Executives
Ruan Jian Chang Director
Jin Ming Hua Executives
Zhou Qian Li Secretary Dong

Zhejiang Zhenyuan Share Co Headlines

No Headlines